Harnessing the Therapeutic Potential of Th17 Cells
Th17 cells provide protective immunity to infections by fungi and extracellular bacteria as well as cancer but are also involved in chronic inflammation. The cells were first identified by their ability to produce interleukin 17A (IL-17A) and, subsequently, associated with chronic inflammation and a...
Saved in:
Main Authors: | Jonas Bystrom (Author), Taher E. Taher (Author), M. Sherwan Muhyaddin (Author), Felix I. Clanchy (Author), Pamela Mangat (Author), Ali S. Jawad (Author), Richard O. Williams (Author), Rizgar A. Mageed (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review
by: Kadry M. Sadek, et al.
Published: (2024) -
The potential role of Th17 lymphocytes in patients with psoriasis
by: Mahnaz Mansouri, et al.
Published: (2018) -
Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease
by: Manuj Ahuja, et al.
Published: (2022) -
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
by: Sagnik Nag, et al.
Published: (2024) -
Harnessing MerTK agonism for targeted therapeutics
by: Vivekananda Kedage, et al.
Published: (2020)